Laura Testa

24 posts

Laura Testa

Laura Testa

@LauraTestaMD

Katılım Mayıs 2019
108 Takip Edilen231 Takipçiler
Laura Testa
Laura Testa@LauraTestaMD·
I am happy that reviewer n3 cannot imagine a reality where people need CVCs and there is no ultrasound. Life can be better with more resources. Congratulations to the authors and all our fellow colleagues who battle to deliver the best possible care wherever it is needed.
Marcio Boniatti@MarcioBoniatti

Today we received responses from reviewers about an article that investigated a training program for CVC insertion.Reviewers, please be empathetic in the responses. Don't be disrespectful like the reviewer 3. Total ignorance of low-middle income country conditions @dvarvaki

English
0
0
6
0
Laura Testa retweetledi
Medscape PT
Medscape PT@MedscapePT·
ASCO 2020: Resultados dos principais estudos sobre câncer de mama e tumores ginecológicos comentados pelas Dras. Laura Testa e Maria del Pilar Estevez-Diz. ms.spr.ly/6010TYtua
Medscape PT tweet media
Português
0
2
10
0
Laura Testa
Laura Testa@LauraTestaMD·
Amazing news from MONARCH E trial. Grateful to all participating!
Laura Testa tweet media
English
0
0
12
0
Laura Testa
Laura Testa@LauraTestaMD·
@AdrianaHepner @amenzies9 @MPostow @HTawbi_MD @jasonlukemd @KimrynRathmell @DrChoueiri @montypal @m_e_nielsen @FaltasLab @ERPlimackMD @BernardAFox @alexshoushtari @RiyueSunnyBao @Aiims1742 @JaniceM10 @jan_beumer @mcquadeMDLAc @evanlipson @YoninaMG @DrBetofMDPhD @OmidHamidMD @FunchainMD @MattCarlino @inespiresilva @DrBenKong @Mal_Itchins @mauriciofribei1 @renata_bonadio @pires_veridiana @davidmuniz_ I pledge to oppose racism and hate through active allyship, continuous unlearning, learning, and listening. Join me by nominating 5 others to do the same. @BraghiroliIgnez @pilarestevezmd @RGuindalini @DrRBarroso @f_g_zampieri @MarianaBrandao0
English
0
0
2
0
Adriana Hepner
Adriana Hepner@AdrianaHepner·
@amenzies9 @MPostow @HTawbi_MD @jasonlukemd @KimrynRathmell @DrChoueiri @montypal @m_e_nielsen @FaltasLab @ERPlimackMD @BernardAFox @alexshoushtari @RiyueSunnyBao @Aiims1742 @JaniceM10 @jan_beumer @mcquadeMDLAc @evanlipson @YoninaMG @DrBetofMDPhD @OmidHamidMD @FunchainMD @MattCarlino @inespiresilva @DrBenKong @Mal_Itchins I pledge to oppose racism and hate through active allyship, continuous unlearning, learning, and listening. Join me by nominating 5 others to do the same. @mauriciofribei1 @renata_bonadio @pires_veridiana @LauraTestaMD @davidmuniz_
English
2
0
5
0
Kimryn Rathmell
Kimryn Rathmell@KimrynRathmell·
I pledge to oppose racism and hate through active allyship, continuous unlearning, learning, and listening. Join me by nominating 5 others to do the same. #BlackLivesMatter @DrChoueiri @montypal @m_e_nielsen @FaltasLab @ERPlimackMD
Blossom Damania 🔬🧬🧪🦠🧫@DamaniaLab

@goodum_viruslab @SesmaLab @GamarnikLab @SalehLabParis @npariente @Lakdawala_Lab @Vineet321 @NLemmermann @10queues @scienceCC @virusninja @AnnaCliffe1 I pledge to oppose racism and hate through active allyship, continuous unlearning, learning, and listening. Join me by nominating 5 others to do the same. #BlackLivesMatter @HPVlabUNC @dnatarheel @KimrynRathmell @peiferlabunc @VirusWhisperer

English
1
3
43
0
Laura Testa
Laura Testa@LauraTestaMD·
@DavidFajgenbaum @ASCO Thank you so much for your inspiring talk! Hope, action, laughter, connection and communication! Stay safe!
English
0
0
3
0
David Fajgenbaum, MD
David Fajgenbaum, MD@DavidFajgenbaum·
Was such an honor to deliver the @ASCO Opening Address. I shared some thoughts about my talk and 5 key messages while receiving my monthly infusion. It felt like a fitting time to share about being a patient-physician-researcher-caregiver-advocate #ASCO20 #ChasingMyCure
English
40
173
795
0
Laura Testa retweetledi
Paulo Hoff
Paulo Hoff@paulohoff10·
Today we discharged home a 97 year old woman who had been admitted to our hospital with a severe COVID infection. Best Easter present ever!
Paulo Hoff tweet media
English
7
31
574
0
Laura Testa retweetledi
Medscape PT
Medscape PT@MedscapePT·
Inibidores da PARP dominaram as novidades em tumores ginecológicos da #ESMO19, assista ao vídeo com um resumo do que foi apresentado: ms.spr.ly/6019TRr0Z
Medscape PT tweet media
Português
0
1
3
0
Laura Testa retweetledi
Veridiana Pires De Camargo
Veridiana Pires De Camargo@pires_veridiana·
Our 10 year follow up of 100 adult osteossarcomas treated with cis -dox without MTX. 5Y OS 67.3%
Veridiana Pires De Camargo tweet media
English
2
2
25
0
Carolina Silva, MD, PhD
Carolina Silva, MD, PhD@carolinasilvaMD·
Hi everyone! Back after a 3 months break due to an unpredictable health issue. I would like to kindly thank all of you for your support, friendship and love. Tks for helping me to get fully recovered. 🙏🙏🙏🙏🙏
English
4
0
13
0
Laura Testa
Laura Testa@LauraTestaMD·
@itsnot_pink I usually already know trials open in my institution. And I look for trials in and outside my workplace every time we start a new treatment, even if there is a good standard of care option.
English
0
1
5
0
Laura Testa retweetledi
FabriceAndre
FabriceAndre@FAndreMD·
we are looking for 2 highly motivated MDPhD to develop clin research and AI-based molecular predictors in the precision medicine center @GustaveRoussy @centralesupelec . excellent mentors. grant for 5 years. pls send applications to fandre@igr.fr
English
0
60
79
0
Laura Testa
Laura Testa@LauraTestaMD·
@f_g_zampieri Very interesting point really, although I want my boss to stick around for at least 20 more...
English
0
0
0
0
Laura Testa
Laura Testa@LauraTestaMD·
@itsnot_pink Julia, patients with other germline mutations such as RAD51c might be responders to PARP inhibition. Unfortunately there is no hint yet that somatic mutations will be good biomarkers for PARPi response. Excluding HER2+ patients is actually a matter of simplifying study design...
English
1
0
1
0
Julia Maués
Julia Maués@itsnot_pink·
3 questions on this: 1) Can PARBs work for patients w/ germline non-BRCA mutation? Which ones? 2) Can PARBs work for patients w/ somatic non-BRCA mutations? Which ones? 3) Why were HER2+ patients left out of PARB approvals (having a BRCA mutations doesn't exclude being HER2+)
UT MD Anderson@UTMDAnderson

“I think a lot is going on in the #PARP inhibitor space, but I think the general theme is expanding responses to people outside of the germline #BRCA mutation carriers, as well as lengthening the duration of response,” says our @JenniferLitton. #ASCO19 #endcancer

English
3
2
9
0

Keşfet

@AdrianaHepner @MPostow @HTawbi_MD @jasonlukemd @KimrynRathmell @DrChoueiri @montypal @m_e_nielsen